Global Antiplatelet Drugs Market to Grow at a CAGR of 7.8% During 2024-2032, Aided by the Advancing Pharmaceuticals Sector and the Increasing Incidences of Thrombosis

The global antiplatelet drugs industry is being driven by the increasing cases of thrombosis and the expanding pharmaceuticals industry. Based on drugs, aspirin is one of the most preferred antiplatelet drugs in the industry. It has been in use since a long time and had received FDA approval in the 1990s. Online pharmacies are expected to significantly contribute to the industry growth over the forecast period, thus, enhancing its market share. This can be attributed to the growing consumer shift towards online services owing to their convenience.

The growing mergers and acquisitions by key players are also aiding the industry. In November 2020, Pfizer Inc. (NYSE: PFE) announced the formation of Viatris Inc after it completed the transaction to spin off its Upjohn business and combine it with Mylan N.V. Further, there has been increasing investments to develop innovative solutions for the patients. In November 2019, Baxter International Inc. (NYSE: BAX), a key player in the industry, and Ayogo Health Inc., a digital health company, together launched CKD&Me, a unique app for smartphones and tablets for chronic kidney disease (CKD) patients to empower and educate them regarding pre-dialysis. Such developments are expected to significantly contribute to the industry growth over the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Drug, Drug Class, Application, Route of Administration, Distribution Channel, and Region:

• The various drugs available in the market are aspirin, clopidogrel, ticagrelor, prasugrel, dipyridamole, ticlopidine, abciximab, and tirofiban, among others. 

• By drug class, the industry can be segmented into platelet aggregation inhibitors, glycoprotein platelet inhibitors, and protease-activated receptor-1 antagonists, among others.

• On the basis of application, the industry has been categorised into myocardial infraction, percutaneous coronary interventions, angioplasty, arterial thrombosis, and dental surgeries, among others. 
• The industry is bifurcated into oral and injectable based on the route of administration. 

• Based on distribution channel, the industry can be divided into hospital pharmacy, retail pharmacy, and online pharmacy, among others.

• Region-wise, the global market for antiplatelet drugs can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for antiplatelet drugs is being driven by the growing cases of thrombosis, increasing availability of advanced diagnostic facilities, and the growing pharmaceuticals industry.

• The favourable government initiatives and the proliferation of anticoagulant/antithrombotic drugs are further propelling the industry growth. 

• The market is receiving a further impetus with the growing technological advancements. 

• The growing R&D activities and the development of new drugs are further propelling the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for antiplatelet drugs for the periods (2018-2023) and (2024-2032). 

• The report also offers historical (2018-2023) and forecast (2024-2032) market information for the drugs, drug classes, applications, routes of administration, distribution channels, and major regions of antiplatelet drugs.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global antiplatelet drugs market are Glenmark Pharmaceuticals Ltd., Sanofi SA, Pfizer Inc., Baxter International Inc., and Bayer AG, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.